|
Mission: Genome Diagnostics aims to offer accurate diagnostic tools to facilitate donor/recipient matching, ultimately leading to higher success rates of bone-marrow, cord blood and stem cell transplantations.
For transplantation there is a high need for a tissue match between patient and the donor. Without a full match there is an increased chance that the transplanted organ or bone marrow may be rejected. Besides many immediate negative effects for the patient, a failed transplantation also affects future transplantation, as the patient may become highly sensitized.
Tissue typing can be carried out by various methods. The preferred method of choice is dependent on several factors like location, access to technology, expertise of personnel and allocated budget. In the UMC Utrecht researchers have developed a strategy that allows typing of the donors and patient at the highest resolution.
This Sequencing Based Strategy (SBT) has become the gold standard. However, proper implementation had been delayed by the availability of adequate software, reliable reagents and proper training and support.
GenDx now offers a comprehensive solution that has already been adopted by a significant number of laboratories worldwide.
HLA-SBT Teaching Session at ASHI
We will be running another HLA-SBT Teaching Session on Sunday 26th September, just prior to the commencement of the annual ASHI conference in Hollywood, Florida. For more information, please follow this link. Please register soon as places are limited.
GenDx Bronze Sponsors of ASHI
We are pleased to announce our bronze sponsorship of ASHI for the coming year. ASHI does a great job for the immunogenetics and transplant immunology world and we are very happy to be able to support this.
GenDx Exhibiting at ASHI, Eurotransplant and APHIA
As well as holding our Teaching Session, GenDx will also be exhibiting at this year's ASHI, together with our partner, Qiagen. Other meetings where we will be exhibiting this year are:
- Eurotransplant, Leiden, the Netherlands. (23rd -24th September)
- APHIA (Asia-Pacific Histocompatibility and Immunogenetics Association) in New Zealand (16th -19th November).
We're looking forward to seeing you there!
QIAGEN Expands Partnership with Genome Diagnostics for Development of New Tests for Applications in Prevention and Personalized Healthcare
We are pleased to announce our new agreement with Qiagen in the field of Personalized Healthcare. For more information please see the accompanying press release
Genome Diagnostics supports the IMGT/HLA database, a specialist database for sequences of the human major histocompatibility complex (HLA). The IMGT/HLA Database is part of the international ImMunoGeneTics project (IMGT).
For more details on the new nomenclature, please click here
For more information on SBTengine and the use of the new nomenclature, please click here
Newsletter
We regularly send out a newsletter with information about latest developments on high resolution typing, SBTengine and HLA-SBT Training Schools. To subscribe to this, please click here.
|
